Results showed that this sandwiched immunoassay successfully detects the presence of different lung cancer associated biomarkers such as CYRFA 21-1, NSE and CEA in the given biological fluid at low concentrations (detection limit 0.97 ng/mL; 0.37 ng/mL; 0.19 ng/mL, respectively). This evidence concerns the gene ENO2 and lung carcinoma.